ym 529 has been researched along with Metastase in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Itoh, T; Kaneko, J; Kidera, Y; Nishida, S; Satou, T; Tanimori, Y; Tsubaki, M; Yamamoto, C; Yamazoe, Y; Yanae, M | 1 |
| Imano, M; Itoh, T; Nishida, S; Ogaki, M; Satou, T; Tsubaki, M; Yanae, M | 1 |
| Kimura, S; Kuroda, J; Maekawa, T; Nogawa, M; Sato, K; Segawa, H; Yokota, A; Yuasa, T | 1 |
3 other study(ies) available for ym 529 and Metastase
| Article | Year |
|---|---|
Nitrogen-containing bisphosphonate, YM529/ONO-5920, inhibits tumor metastasis in mouse melanoma through suppression of the Rho/ROCK pathway.
Topics: Animals; Base Sequence; Blotting, Western; Cell Line, Tumor; Diphosphonates; DNA Primers; Female; Imidazoles; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Polymerase Chain Reaction; rho-Associated Kinases | 2010 |
Reduction of metastasis, cell invasion, and adhesion in mouse osteosarcoma by YM529/ONO-5920-induced blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathway.
Topics: Animals; Cell Adhesion; Cell Line, Tumor; Cell Movement; Diphosphonates; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Neoplastic; Imidazoles; Male; Matrix Metalloproteinases; Mice; Mice, Inbred C3H; Mitogen-Activated Protein Kinase Kinases; Neoplasm Invasiveness; Neoplasm Metastasis; Osteosarcoma; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; ras Proteins; RNA, Messenger | 2012 |
Monitoring luciferase-labeled cancer cell growth and metastasis in different in vivo models.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Diagnostic Imaging; Diphosphonates; Disease Models, Animal; Humans; Imidazoles; Luciferases; Luminescent Measurements; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms | 2005 |